Cargando…
Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 2...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337811/ https://www.ncbi.nlm.nih.gov/pubmed/34918030 http://dx.doi.org/10.1093/brain/awab437 |
_version_ | 1784759835738243072 |
---|---|
author | Pottier, Cyril Mateiu, Ligia Baker, Matthew C DeJesus-Hernandez, Mariely Teixeira Vicente, Cristina Finch, NiCole A Tian, Shulan van Blitterswijk, Marka Murray, Melissa E Ren, Yingxue Petrucelli, Leonard Oskarsson, Björn Biernacka, Joanna M Graff-Radford, Neill R Boeve, Bradley F Petersen, Ronald C Josephs, Keith A Asmann, Yan W Dickson, Dennis W Rademakers, Rosa |
author_facet | Pottier, Cyril Mateiu, Ligia Baker, Matthew C DeJesus-Hernandez, Mariely Teixeira Vicente, Cristina Finch, NiCole A Tian, Shulan van Blitterswijk, Marka Murray, Melissa E Ren, Yingxue Petrucelli, Leonard Oskarsson, Björn Biernacka, Joanna M Graff-Radford, Neill R Boeve, Bradley F Petersen, Ronald C Josephs, Keith A Asmann, Yan W Dickson, Dennis W Rademakers, Rosa |
author_sort | Pottier, Cyril |
collection | PubMed |
description | Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 24 FTLD-TDP patients with GRN mutations and 24 control participants. Using principal component analysis, hierarchical clustering, differential expression and coexpression network analyses, we showed that GRN mutation carriers and FTLD-TDP-A patients without a known mutation shared a common transcriptional signature that is independent of GRN loss-of-function. After combining both groups, differential expression as compared to the control group and coexpression analyses revealed alteration of processes related to immune response, synaptic transmission, RNA metabolism, angiogenesis and vesicle-mediated transport. Deconvolution of the data highlighted strong cellular alterations that were similar in FTLD-TDP-A and GRN mutation carriers with NSF as a potentially important player in both groups. We propose several potentially druggable pathways such as the GABAergic, GDNF and sphingolipid pathways. Our findings underline new disease mechanisms and strongly suggest that affected pathways in GRN mutation carriers extend beyond GRN and contribute to genetically unexplained forms of FTLD-TDP-A. |
format | Online Article Text |
id | pubmed-9337811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93378112022-08-01 Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations Pottier, Cyril Mateiu, Ligia Baker, Matthew C DeJesus-Hernandez, Mariely Teixeira Vicente, Cristina Finch, NiCole A Tian, Shulan van Blitterswijk, Marka Murray, Melissa E Ren, Yingxue Petrucelli, Leonard Oskarsson, Björn Biernacka, Joanna M Graff-Radford, Neill R Boeve, Bradley F Petersen, Ronald C Josephs, Keith A Asmann, Yan W Dickson, Dennis W Rademakers, Rosa Brain Original Article Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 24 FTLD-TDP patients with GRN mutations and 24 control participants. Using principal component analysis, hierarchical clustering, differential expression and coexpression network analyses, we showed that GRN mutation carriers and FTLD-TDP-A patients without a known mutation shared a common transcriptional signature that is independent of GRN loss-of-function. After combining both groups, differential expression as compared to the control group and coexpression analyses revealed alteration of processes related to immune response, synaptic transmission, RNA metabolism, angiogenesis and vesicle-mediated transport. Deconvolution of the data highlighted strong cellular alterations that were similar in FTLD-TDP-A and GRN mutation carriers with NSF as a potentially important player in both groups. We propose several potentially druggable pathways such as the GABAergic, GDNF and sphingolipid pathways. Our findings underline new disease mechanisms and strongly suggest that affected pathways in GRN mutation carriers extend beyond GRN and contribute to genetically unexplained forms of FTLD-TDP-A. Oxford University Press 2021-12-16 /pmc/articles/PMC9337811/ /pubmed/34918030 http://dx.doi.org/10.1093/brain/awab437 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Pottier, Cyril Mateiu, Ligia Baker, Matthew C DeJesus-Hernandez, Mariely Teixeira Vicente, Cristina Finch, NiCole A Tian, Shulan van Blitterswijk, Marka Murray, Melissa E Ren, Yingxue Petrucelli, Leonard Oskarsson, Björn Biernacka, Joanna M Graff-Radford, Neill R Boeve, Bradley F Petersen, Ronald C Josephs, Keith A Asmann, Yan W Dickson, Dennis W Rademakers, Rosa Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations |
title | Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations |
title_full | Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations |
title_fullStr | Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations |
title_full_unstemmed | Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations |
title_short | Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations |
title_sort | shared brain transcriptomic signature in tdp-43 type a ftld patients with or without grn mutations |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337811/ https://www.ncbi.nlm.nih.gov/pubmed/34918030 http://dx.doi.org/10.1093/brain/awab437 |
work_keys_str_mv | AT pottiercyril sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT mateiuligia sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT bakermatthewc sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT dejesushernandezmariely sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT teixeiravicentecristina sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT finchnicolea sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT tianshulan sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT vanblitterswijkmarka sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT murraymelissae sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT renyingxue sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT petrucellileonard sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT oskarssonbjorn sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT biernackajoannam sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT graffradfordneillr sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT boevebradleyf sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT petersenronaldc sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT josephskeitha sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT asmannyanw sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT dicksondennisw sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations AT rademakersrosa sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations |